Trial Profile
A Phase IIb clinical Trial of Disitertide (P144) in patients with Systemic Sclerosis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2015
Price :
$35
*
At a glance
- Drugs Disitertide (Primary)
- Indications Systemic scleroderma
- Focus Adverse reactions; Therapeutic Use
- 07 Oct 2015 New trial record